Clinical Trials
1
Active:0
Completed:0
Trial Phases
1 Phases
Phase 2:1
Drug Approvals
80
TGA:80
Drug Approvals
SPEVIGO spesolimab (rch) 450 mg in 7.5 mL concentrated solution for infusion vial (388597)
- Product Name
- SPEVIGO spesolimab (rch) 450 mg in 7.5 mL concentrated solution for infusion vial
- Approval Date
- Nov 24, 2023
TGA
STRIVERDI RESPIMAT olodaterol (as hydrochloride) 2.5 microgram/actuation solution for inhalation cartridge (with dose indicator) (326012)
- Product Name
- STRIVERDI RESPIMAT olodaterol (as hydrochloride) 2.5 microgram/actuation solution for inhalation cartridge (with dose indicator)
- Approval Date
- Apr 17, 2020
TGA
SPIRIVA RESPIMAT tiotropium 2.5 micrograms/actuation solution for inhalation cartridge (with dose indicator) (325662)
- Product Name
- SPIRIVA RESPIMAT tiotropium 2.5 micrograms/actuation solution for inhalation cartridge (with dose indicator)
- Approval Date
- Mar 4, 2020
TGA
SPIOLTO RESPIMAT 2.5 micrograms/2.5 micrograms tiotropium/olodaterol solution for inhalation cartridge (with dose indicator) (326008)
- Product Name
- SPIOLTO RESPIMAT 2.5 micrograms/2.5 micrograms tiotropium (as bromide monohydrate)/olodaterol (as hydrochloride) solution for inhalation cartridge (with dose indicator)
- Approval Date
- Mar 4, 2020
TGA
SRIVASSO RESPIMAT tiotropium 2.5 micrograms/actuation solution for inhalation cartridge (with dose indicator) (325664)
- Product Name
- SRIVASSO RESPIMAT tiotropium 2.5 micrograms/actuation solution for inhalation cartridge (with dose indicator)
- Approval Date
- Mar 4, 2020
TGA
ESOVYND RESPIMAT tiotropium 2.5 micrograms/actuation solution for inhalation cartridge (with dose indicator) (325663)
- Product Name
- ESOVYND RESPIMAT tiotropium 2.5 micrograms/actuation solution for inhalation cartridge (with dose indicator)
- Approval Date
- Mar 4, 2020
TGA
YANIMO RESPIMAT 2.5 micrograms/2.5 micrograms tiotropium/olodaterol solution for inhalation cartridge (with dose indicator) (326009)
- Product Name
- YANIMO RESPIMAT 2.5 micrograms/2.5 micrograms tiotropium (as bromide monohydrate)/olodaterol (as hydrochloride) solution for inhalation cartridge (with dose indicator)
- Approval Date
- Mar 4, 2020
TGA
GLYXAMBI 10 mg/5 mg empagliflozin/linagliptin 10mg/5mg film coated tablet blister pack (263556)
- Product Name
- GLYXAMBI 10 mg/5 mg empagliflozin/linagliptin 10mg/5mg film coated tablet blister pack
- Approval Date
- Dec 19, 2016
TGA
GLYXAMBI 25 mg/5 mg empagliflozin/linagliptin 25mg/5mg film coated tablet blister pack (263557)
- Product Name
- GLYXAMBI 25 mg/5 mg empagliflozin/linagliptin 25mg/5mg film coated tablet blister pack
- Approval Date
- Dec 19, 2016
TGA
SRIVASSO tiotropium 18 micrograms powder for inhalation (in capsule) blister pack (269417)
- Product Name
- SRIVASSO tiotropium 18 micrograms powder for inhalation (in capsule) blister pack
- Approval Date
- Jun 8, 2016
TGA
- Prev
- 1
- 2
- 3
- 4
- 5
- 8
- Next
Clinical Trials
Distribution across different clinical trial phases (1 trials with phase data)• Click on a phase to view related trials
Phase 2
1 (100.0%)No trials found
News
No news found